LifeMD, Inc. (LFMD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

LifeMD, Inc. (LFMD) is up 33.7% since the beginning of the year. At $5 per share, LFMD is trading 71.2% below its 52-week high of $16. Investors who bought $1,000 worth of LFMD shares 5 years ago would now be looking at an investment worth $336.

LifeMD, Inc. (LFMD) has returned 33.72% so far this year and -63.95% over the past 12 months. Over the last ten years, LFMD has returned 12.87% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Jan 2, 2001, LFMD's average daily return is +0.64%, while the average monthly return is +5.91%. At this rate, an investment would double in approximately 1.0 years.

Historically, 43% of months were positive and 57% were negative. The best month was Jan 2021 with a return of +218.8%, while the worst month was Dec 2001 at -58.3%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 8 months.

On a daily basis, LFMD closed higher 30% of trading days. The best single day was Dec 13, 2002 with a return of +100.0%, while the worst single day was Aug 23, 2001 at -50.0%.

LifeMD, Inc. has an annualized alpha of 373.03%, beta of 0.64, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since January 03, 2001.

• This stock captured 36.03% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -19.11%) - a profile typical of hedging or uncorrelated assets.
• Beta of 0.64 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

LFMD ranks 15 for risk / return — in the bottom 15% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for LifeMD, Inc. (LFMD) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the LifeMD, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the LifeMD, Inc. was 96.24%, occurring on Mar 17, 2023. The portfolio has not yet recovered.

The current LifeMD, Inc. drawdown is 85.07%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of LifeMD, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how LifeMD, Inc. is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.